- Home
- LYT vs SHPH Comparison
LYT vs SHPH Comparison
Compare LYT & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYT
- SHPH
- Stock Information
- Founded
- LYT 2020
- SHPH 2012
- Country
- LYT India
- SHPH United States
- Employees
- LYT N/A
- SHPH N/A
- Industry
- LYT EDP Services
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- LYT Technology
- SHPH Health Care
- Exchange
- LYT Nasdaq
- SHPH Nasdaq
- Market Cap
- LYT 3.8M
- SHPH 3.9M
- IPO Year
- LYT 2022
- SHPH 2022
- Fundamental
- Price
- LYT $1.69
- SHPH $1.00
- Analyst Decision
- LYT
- SHPH
- Analyst Count
- LYT 0
- SHPH 0
- Target Price
- LYT N/A
- SHPH N/A
- AVG Volume (30 Days)
- LYT 70.3K
- SHPH 3.4M
- Earning Date
- LYT 08-15-2024
- SHPH 11-13-2024
- Dividend Yield
- LYT N/A
- SHPH N/A
- EPS Growth
- LYT N/A
- SHPH N/A
- EPS
- LYT 0.30
- SHPH N/A
- Revenue
- LYT $21,363,775.00
- SHPH N/A
- Revenue This Year
- LYT N/A
- SHPH N/A
- Revenue Next Year
- LYT N/A
- SHPH N/A
- P/E Ratio
- LYT $5.68
- SHPH N/A
- Revenue Growth
- LYT 12.39
- SHPH N/A
- 52 Week Low
- LYT $1.40
- SHPH $0.98
- 52 Week High
- LYT $18.62
- SHPH $4.94
- Technical
- Relative Strength Index (RSI)
- LYT 44.25
- SHPH 35.05
- Support Level
- LYT $1.67
- SHPH $1.22
- Resistance Level
- LYT $2.04
- SHPH $1.23
- Average True Range (ATR)
- LYT 0.13
- SHPH 0.20
- MACD
- LYT -0.00
- SHPH -0.04
- Stochastic Oscillator
- LYT 16.67
- SHPH 1.73
About LYT Lytus Technologies Holdings PTV. Ltd.
Lytus Technologies Holdings Pvt Ltd is a platform services company providing content streaming/telecasting services to users located all across India. Its scope of business also covers telemedicine services with local assistance through local Health Centers. Through its platform, the customers are well connected via customer premises equipment (CPE) devices/set-top boxes (STBs) and have access to multi-dimensional services including telemedicine service.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.